The NNPDF Central Office has received a copy of a recent publication by Dr. Andrew Munkacsi, an NNPDF/CCNNPDF funded fellow, that provides insight into Vorinostat as a candidate therapy to treat NPC Disease via the first animal study in a model of NPC disease.